Daxxify Revance Therapeutics

Daxxify

Nashville-based Revance Therapeutics is slated to be acquired and taken private by Crown Laboratories.

Johnson City, Tenn.- based Crown will absorb Revance by year’s end in a deal valued at $924 million, or $6.66 per share, according to a press release.